Literature DB >> 27162792

Importance of tumor infiltrating lymphocytes in non-small cell lung cancer?

Roy M Bremnes1, Tom Donnem1, Lill-Tove Busund1.   

Abstract

Entities:  

Year:  2016        PMID: 27162792      PMCID: PMC4842396          DOI: 10.21037/atm.2016.03.28

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  18 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Prognostic Role of Tumor-Infiltrating Lymphocytes in Lung Cancer: a Meta-Analysis.

Authors:  Yiting Geng; Yingjie Shao; Wenting He; Wenwei Hu; Yanjie Xu; Jun Chen; Changping Wu; Jingting Jiang
Journal:  Cell Physiol Biochem       Date:  2015-10-30

3.  Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer.

Authors:  Tom Donnem; Sigurd M Hald; Erna-Elise Paulsen; Elin Richardsen; Samer Al-Saad; Thomas K Kilvaer; Odd Terje Brustugun; Aslaug Helland; Marius Lund-Iversen; Mette Poehl; Karen Ege Olsen; Henrik J Ditzel; Olfred Hansen; Khalid Al-Shibli; Yury Kiselev; Torkjel M Sandanger; Sigve Andersen; Francesco Pezzella; Roy M Bremnes; Lill-Tove Busund
Journal:  Clin Cancer Res       Date:  2015-02-13       Impact factor: 12.531

Review 4.  Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer.

Authors:  T Donnem; T K Kilvaer; S Andersen; E Richardsen; E E Paulsen; S M Hald; S Al-Saad; O T Brustugun; A Helland; M Lund-Iversen; S Solberg; B H Gronberg; S G F Wahl; L Helgeland; O Fløtten; M Pohl; K Al-Shibli; T M Sandanger; F Pezzella; L T Busund; R M Bremnes
Journal:  Ann Oncol       Date:  2015-11-16       Impact factor: 32.976

5.  Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.

Authors:  Khalid I Al-Shibli; Tom Donnem; Samer Al-Saad; Magnus Persson; Roy M Bremnes; Lill-Tove Busund
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

6.  Adaptive immunity maintains occult cancer in an equilibrium state.

Authors:  Catherine M Koebel; William Vermi; Jeremy B Swann; Nadeen Zerafa; Scott J Rodig; Lloyd J Old; Mark J Smyth; Robert D Schreiber
Journal:  Nature       Date:  2007-11-18       Impact factor: 49.962

Review 7.  The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer.

Authors:  Roy M Bremnes; Lill-Tove Busund; Thomas L Kilvær; Sigve Andersen; Elin Richardsen; Erna Elise Paulsen; Sigurd Hald; Mehrdad Rakaee Khanehkenari; Wendy A Cooper; Steven C Kao; Tom Dønnem
Journal:  J Thorac Oncol       Date:  2016-02-01       Impact factor: 15.609

Review 8.  Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Authors:  Robert D Schreiber; Lloyd J Old; Mark J Smyth
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

9.  Objective measurement and clinical significance of TILs in non-small cell lung cancer.

Authors:  Kurt A Schalper; Jason Brown; Daniel Carvajal-Hausdorf; Joseph McLaughlin; Vamsidhar Velcheti; Konstantinos N Syrigos; Roy S Herbst; David L Rimm
Journal:  J Natl Cancer Inst       Date:  2015-02-03       Impact factor: 11.816

Review 10.  Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

Authors:  Jérôme Galon; Bernhard Mlecnik; Gabriela Bindea; Helen K Angell; Anne Berger; Christine Lagorce; Alessandro Lugli; Inti Zlobec; Arndt Hartmann; Carlo Bifulco; Iris D Nagtegaal; Richard Palmqvist; Giuseppe V Masucci; Gerardo Botti; Fabiana Tatangelo; Paolo Delrio; Michele Maio; Luigi Laghi; Fabio Grizzi; Martin Asslaber; Corrado D'Arrigo; Fernando Vidal-Vanaclocha; Eva Zavadova; Lotfi Chouchane; Pamela S Ohashi; Sara Hafezi-Bakhtiari; Bradly G Wouters; Michael Roehrl; Linh Nguyen; Yutaka Kawakami; Shoichi Hazama; Kiyotaka Okuno; Shuji Ogino; Peter Gibbs; Paul Waring; Noriyuki Sato; Toshihiko Torigoe; Kyogo Itoh; Prabhu S Patel; Shilin N Shukla; Yili Wang; Scott Kopetz; Frank A Sinicrope; Viorel Scripcariu; Paolo A Ascierto; Francesco M Marincola; Bernard A Fox; Franck Pagès
Journal:  J Pathol       Date:  2014-01       Impact factor: 7.996

View more
  4 in total

1.  Image analysis reveals molecularly distinct patterns of TILs in NSCLC associated with treatment outcome.

Authors:  Ruiwen Ding; Prateek Prasanna; Germán Corredor; Cristian Barrera; Philipp Zens; Cheng Lu; Priya Velu; Patrick Leo; Niha Beig; Haojia Li; Paula Toro; Sabina Berezowska; Vipul Baxi; David Balli; Merzu Belete; David L Rimm; Vamsidhar Velcheti; Kurt Schalper; Anant Madabhushi
Journal:  NPJ Precis Oncol       Date:  2022-06-03

2.  Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis.

Authors:  Vanda Téglási; Lilla Reiniger; Katalin Fábián; Orsolya Pipek; Irén Csala; Attila G Bagó; Péter Várallyai; Laura Vízkeleti; Lívia Rojkó; József Tímár; Balázs Döme; Zoltán Szállási; Charles Swanton; Judit Moldvay
Journal:  Neuro Oncol       Date:  2017-08-01       Impact factor: 12.300

3.  Tumour infiltrating lymphocytes correlate with improved survival in patients with esophageal squamous cell carcinoma.

Authors:  Dongxian Jiang; Yalan Liu; Hao Wang; Haixing Wang; Qi Song; Akesu Sujie; Jie Huang; Yifan Xu; Haiying Zeng; Lijie Tan; Yingyong Hou; Chen Xu
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

4.  CD8+ tumor-infiltrating lymphocytes as a novel prognostic biomarker in lung sarcomatoid carcinoma, a rare subtype of lung cancer.

Authors:  Jiewei Chen; Qingmei He; Jun Liu; Yongbo Xiao; Canhua Xiao; Keming Chen; Dan Xie; Xinke Zhang
Journal:  Cancer Manag Res       Date:  2018-09-13       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.